Vizora日本語

Premier Anti-AgingPremier Anti-Aging Co., Ltd.4934東証グロース化学FY ending Jul 2025, consolidated, J-GAAP

Premier Anti-Aging FY ending Jul 2025 results

About 80% of Premier Anti-Aging's sales come from Antiaging, with Recovery making up much of the rest.

Out of every ¥100 of sales, about ¥4 is left as operating profit.

Revenue changed -20.6% from the prior year, operating profit +343.9%.

Revenue and profit pattern

Revenue down, profit up

Revenue -20.6% · profit +343.9%, calculated from disclosed figures.

Operating leverage: -16.67× (profit growth ÷ revenue growth)

What changed from last year

FY ending Jul 2024 → FY ending Jul 2025

Revenue
-20.6%¥20.4B → ¥16.2B
Gross profit
-23.1%¥16.1B → ¥12.4B
Operating income
+343.9%¥139M → ¥617M
Net income attributable to owners
Back to profit-¥1.48B → ¥471M
Operating cash flow
+246.4%¥425M → ¥1.47B
Free cash flow
Back to profit-¥395M → ¥1.28B

Where the money goes

FY ending Jul 2024 → FY ending Jul 2025

Where ¥100 of sales goes

For every ¥100 Premier Anti-Aging sells, how much goes where, and how much is kept.

FY ending Jul 2025
Cost of sales
¥23
SG&A
¥73
Operating profit
¥4
Net profit kept
¥3

Annual margin trends

Gross margin76.6%
FY ending Jul 2020: 80.4%80.4%FY ending Jul 2021: 80.5%80.5%FY ending Jul 2022: 78.5%78.5%FY ending Jul 2023: 72.9%72.9%FY ending Jul 2024: 79.1%79.1%FY ending Jul 2025: 76.6%76.6%FY20FY21FY22FY23FY24FY25
Operating margin3.8%
FY ending Jul 2020: 8.1%8.1%FY ending Jul 2021: 14.3%14.3%FY ending Jul 2022: 7.1%7.1%FY ending Jul 2023: -2.3%-2.3%FY ending Jul 2024: 0.7%0.7%FY ending Jul 2025: 3.8%3.8%FY20FY21FY22FY23FY24FY25
Net margin2.9%
FY ending Jul 2020: 5.6%5.6%FY ending Jul 2021: 8.5%8.5%FY ending Jul 2022: 4.2%4.2%FY ending Jul 2023: -2.8%-2.8%FY ending Jul 2024: -7.3%-7.3%FY ending Jul 2025: 2.9%2.9%FY20FY21FY22FY23FY24FY25

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Jul 2025

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (6)

  • EDINET (FSA Japan)

    訂正有価証券報告書－第16期(2024/08/01－2025/07/31)

    ID S100YTAL2026-07-30Open

  • EDINET (FSA Japan)

    有価証券報告書－第15期(2023/08/01－2024/07/31)

    ID S100ULPV2024-10-30Open

  • EDINET (FSA Japan)

    有価証券報告書－第14期(2022/08/01－2023/07/31)

    ID S100S3D02023-10-30Open

  • EDINET (FSA Japan)

    訂正有価証券報告書－第13期(令和3年8月1日－令和4年7月31日)

    ID S100PSUA2022-12-14Open

  • EDINET (FSA Japan)

    有価証券報告書－第12期(令和2年8月1日－令和3年7月31日)

    ID S100MOK92021-10-29Open

  • EDINET (FSA Japan)

    訂正有価証券報告書－第7期(令和1年8月1日－令和2年7月31日)

    ID S100KYP92021-03-15Open

Extracted from XBRL: 49 / Derived from other figures: 2

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image